Setastine
 | |
 | |
| Systematic (IUPAC) name | |
|---|---|
|
1-[2-[1-(4-chlorophenyl)-1-phenyl-ethoxy]ethyl]azepane | |
| Identifiers | |
| CAS Number | 59767-13-4 |
| PubChem | CID 43082 |
| ChemSpider | 39258 |
| UNII |
6G3OCF528J  |
| Chemical data | |
| Formula | C22H28ClNO |
| Molar mass | 357.92 g/mol |
| |
Setastine (Loderix) is an antihistamine used to treat allergies and rhinitis.[1][2]
Pharmacology
Pharmacodynamics
Setastine acts as a highly selective H1 receptor antagonist.[3] It has no anticholinergic, antiadrenergic, or antiserotonergic effects.
Pharmacokinetics
Setastine penetrates the blood-brain-barrier only weakly, hence, it is not sedating or is only mildly so.[3]
See also
References
- ↑ Lantos A, Tóth A, Zsiray M (1991). "Loderix (setastine) tablets in the treatment of allergic rhinoconjunctivitis". Therapia Hungarica (English Edition) 39 (1): 22–4. PMID 1677500.
- ↑ Hirschberg A, Ribári O, Krasznai M (1989). "Results obtained with Loderix tablet in chronic rhinitis patients". Therapia Hungarica (English Edition) 37 (4): 202–4. PMID 2576575.
- 1 2 Porszász J, Varga F, Porszász KG, et al. (December 1990). "Pharmacology of the new H1-receptor antagonist setastine hydrochloride". Arzneimittel-Forschung 40 (12): 1340–5. PMID 1982751.
| ||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Wednesday, September 02, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.